(Q38035753)

27 August 2017

title

Taurine and central nervous system disorders (English)

1 reference

27 August 2017

0 references

3

Howard Prentice

1 reference

27 August 2017

4

Jang-Yen Wu

1 reference

27 August 2017

2

Chunliu Pan

1 reference

27 August 2017

1

Janet Menzie

1 reference

27 August 2017

publication date

19 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

46

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

31-46

1 reference

Alternative excitotoxic hypotheses

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The functional anatomy of basal ganglia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine interaction with neurotransmitter receptors in the CNS: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

A preliminary study of free amino acids in the postmortem temporal cortex from Alzheimer-type dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The undertow of sulfur metabolism on glutamatergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Long-term depression in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Impairment of the ubiquitin-proteasome system by protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Global changes to the ubiquitin system in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Neurotoxic protein oligomers--what you see is not always what you get.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine--a possible neurotransmitter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Sites of [3H]taurine Uptake in the Rat Substantia Nigra in Relation to the Release of Taurine from the Striatonigral Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Primate models of movement disorders of basal ganglia origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Cellular glutathione and thiols metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine increases mitochondrial buffering of calcium: role in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine as a modulator of excitatory and inhibitory neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Conformational properties of alpha-synuclein in its free and lipid-associated states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

A specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The neostriatal mosaic: multiple levels of compartmental organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mitochondrial defect in Huntington's disease caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

{beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The presenilins in Alzheimer's disease--proteolysis holds the key.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Retinal Degeneration Associated with Taurine Deficiency in the Cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure: involvement of mitochondrial complex I assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Solution state characterization of amyloid beta-derived diffusible ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

New aspects of genetic contributions to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

alpha-synuclein promotes mitochondrial deficit and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine in the central nervous system and the mammalian actions of taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Identification of p53 as a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The history of iron in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Co-operativity in sodium-independent taurine binding to brain membranes in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Polyglutamine aggregates stimulate ER stress signals and caspase-12 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Molecular characterization and expression pattern of taurine transporter in zebrafish during embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Identification of two taurine receptor subtypes on the primary afferent terminal of frog spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Role of naturally occurring osmolytes in protein folding and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

George Huntington (1850-1916) and hereditary chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Protective function of taurine in glutamate-induced apoptosis in cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine might be acting as a trophic factor in the retina by modulating phosphorylation of cellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine receptors in membranes from retinal pigment epithelium cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Colocalization of taurine- and cysteine sulfinic acid decarboxylase-like immunoreactivity in the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mechanisms of taurine antihypoxic and antioxidant action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Synthesis and release of neuroactive substances by glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Advances fuel Alzheimer's conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Substantia nigra osmoregulation: taurine and ATP involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Glutathione depletion and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

MPTP, MPP+ and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine-induced attenuation of MPP+ neurotoxicity in vitro: a possible role for the GABA(A) subclass of GABA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine levels in discrete brain nuclei of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine protection of PC12 cells against endoplasmic reticulum stress induced by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Stimulus-coupled taurine efflux from cerebellar neuronal cultures: on the roles of Ca++ and Na+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Misfolded proteins, endoplasmic reticulum stress and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Biogenic amine specificity of cortical peptide synthesis in monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Differential loss of striatal projection neurons in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine increases rat survival and reduces striatal damage caused by 3-nitropropionic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Intrastriatal taurine increases striatal extracellular dopamine in a tetrodotoxin-sensitive manner in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine and neural cell damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mechanisms underlying taurine-mediated alterations in membrane function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Role of osmoregulation in the actions of taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Role of antioxidant activity of taurine in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Alzheimer's disease is a synaptic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Neuronal activity in the subthalamic nucleus modulates the release of dopamine in the monkey striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Cytotoxic and genotoxic potential of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Kinetic Studies on the Inhibition of GABA-T by γ-Vinyl GABA and Taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Identification and partial characterization of putative taurine receptor proteins from the olfactory organ of the spiny lobster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Amyloid β peptide oligomers directly activate NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Purification and characterization of cysteic acid and cysteine sulfinic acid decarboxylase and L-glutamate decarboxylase from bovine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Role of taurine in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Tissue and regional distribution of cysteic acid decarboxylase. A new assay method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mode of action of taurine as a neuroprotector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mechanism of neuroprotective function of taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Regulated formation of Golgi secretory vesicles containing Alzheimer beta-amyloid precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Taurine inhibits rat substantia nigra pars reticulata neurons by activation of GABA- and glycine-linked chloride conductance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

PUMA induces the rapid apoptosis of colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-012-1382-Z

10.1007/S00726-012-1382-Z

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference